Smouldering Waldenstrom's macroglobulinemia: Factors predicting evolution to symptomatic disease

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 231-235

  Cesana, Clara ^a,b   Miqueleiz, Sara ^a,b   Bernuzzi, Patrizia ^a,b   Tresoldi, Elisabetta ^a,b   Rossi, Valentina ^a,b   D'Avanzo, Giovanna ^a,b   Filippini, Davide ^a,b   Morra, Enrica ^a,b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN M; PARAPROTEIN;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LYMPHOCYTE; MALE; PARAPROTEINEMIA; PLASMA CELL; PREDICTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0242670015     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50056     Document Type: Article

References (16)

1. Dhodapkar MV, Jacobson JL, Gertz MA, et al: Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003). Blood 98:41-48, 2001
2. García-Sanz R, Montoto S, Torrequebrada A, et al: Waldenström macroglobulinemia: Presenting features and outcome in a series with 217 cases. Br J Haematol 115:575-582, 2001
3. Facon T, Brouillard M, Duhamel A, et al: Prognostic factors in Waldenström's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
4. Morel P, Monconduit M, Jacomy D, et al: Prognostic factors in Waldenström macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852-858, 2000
5. Gobbi PG, Bettini R, Montecucco C, et al: Study of prognosis in Waldenström's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939-2945, 1994
6. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731, 1987
7. Owen RG, Barrans SL, Richards SJ, et al: Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol 116, 420-428, 2001
8. Baldini L, Guffanti A, Cesana BM, et al: Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood 87:912-918, 1996
9. Cesana C, Klersy C, Barbarano L, et al: Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 20:1625-1634, 2002
10. Bartl R, Frisch B, Mahl G, et al: Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition. Scand J Haematol 31:359-375, 1983
11. Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, et al: Waldenström's macroglobulinemia: Clinical course and prognostic factors in 60 patients. Ann Hematol 80:722-727, 2001
12. Dimopoulos MA, Panayiotidis P, Maulopoulos LA, et al: Waldenström's macroglobulinemia: Clinical features, complications, and management. J Clin Oncol 18:214-226, 2000
13. Owen RG, Johnson SA, Morgan GJ: Waldenström's macroglobulinemia: laboratory diagnosis and treatment. Hematol Oncol 18:41-49, 2000
14. Waldenström JG: Macroglobulinemia - A review. Haematologica 71:437-440, 1986
15. Gertz MA, Fonseca R, Rajkumar SV: Waldenström's macroglobulinemia. Oncologist 5:63-67, 2000
16. McAllister BD, Bayrd RD, Harrison EG Jr, et al: Primary macroglobulinemia. Review with a report on thirty one cases and notes on the value of continuous chlorambucit therapy. Am J Med 43:394-434, 1967